Cubist Systematic Strategies, LLC Aptinyx Inc. Transaction History

Cubist Systematic Strategies, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.38 - $2.58 $1,026 - $6,966	-2,700 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$2.27 - $3.62 $506 - $807	-223 Reduced 7.63%	2,700 $6,000
Q4 2021 Feb 14, 2022	BUY	$2.11 - $3.0 $6,167 - $8,769	2,923 New	2,923 $8,000
Q3 2021 Nov 15, 2021	SELL	$2.21 - $2.89 $66,165 - $86,523	-29,939 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$2.39 - $3.5 $71,554 - $104,786	29,939 New	29,939 $85,000
Q1 2021 May 17, 2021	SELL	$2.86 - $4.33 $47,927 - $72,562	-16,758 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$2.93 - $4.3 $49,100 - $72,059	16,758 New	16,758 $58,000
Q2 2019 Aug 14, 2019	SELL	$2.95 - $4.38 $48,067 - $71,367	-16,294 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$3.99 - $19.33 $57,096 - $276,612	14,310 Added 721.27%	16,294 $66,000
Q4 2018 Feb 14, 2019	BUY	$16.15 - $28.93 $32,041 - $57,397	1,984 New	1,984 $33,000

Ticker APTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,715,696
Description
Aptinyx Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel, proprietary, and synthetic small molecules for the treatment of brain and nervous system disorders. The company is developing NYX-2925, which is in Phase II clinical development for the treatment of painful diabetic pe...

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.